Michael George Robinson Giles

Mr. Michael George Robinson Giles

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Seyed Ebrahim AlaviSeyed Ebrahim Alavi
Seyed Ebrahim Alavi
ARAun Raza
Aun Raza
MGMax Gholami
Max Gholami
MGMichael George Robinson Giles
Michael George Robinson Giles
RARayan Al-Sammak
Rayan Al-Sammak
LSLavanya Ajay Sharma
Lavanya Ajay Sharma
The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted.
1